Peptic Ulcer

64 registered clinical trials studyying Peptic Ulcer — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Predicting Peptic Complications Using H. Pylori Serology and Gastric Ultrasound NCT07458490	Assiut University	—
Not Yet Recruiting	The Effect of Vascular Imaging Devices on Success Rates of Peripheral Vascular Access in Pediatric Patients NCT07315711	Sibel Seçkin Pehlivan	—
Recruiting	Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment NCT07139366	Yongquan Shi	Phase 4
Recruiting	Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic Ulcers NCT06439563	Onconic Therapeutics Inc.	Phase 3
Recruiting	Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic NCT07260006	Can Tho University of Medicine and Pharmacy	N/A
Completed	Ulcer Pomegranate Muffins NCT07123259	University of Lahore	N/A
Recruiting	Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer NCT06284876	Il-Yang Pharm. Co., Ltd.	Phase 3
Completed	Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intesti NCT05742568	Xijing Hospital of Digestive Diseases	Phase 4
Active Not Recruiting	To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children. NCT04702542	Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan	N/A
Completed	Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer NCT04784910	Daewoong Pharmaceutical Co. LTD.	Phase 3
Completed	Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing NCT04678492	Xijing Hospital of Digestive Diseases	Phase 4
Completed	Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadrup NCT05237115	Xijing Hospital of Digestive Diseases	Phase 4
Completed	The Prevalence of Helicobacter Pylori in Shanghai, 2013 to 2019 NCT04636866	Shanghai Jiao Tong University School of Medicine	—
Terminated	Effectiveness of GastimunHp Plus in Supporting the Treatment of Peptic Ulcer Disease With Helicobacter Pylori NCT04025983	Institute of Gastroenterology and Hepatology, Vietnam	N/A
Unknown	Japanese Upper GI Symptoms Compared With Iranian and Canadian Patients Presenting NCT03868267	Hamilton Health Sciences Corporation	—
Unknown	Volatiles in Breath and Headspace Analysis - Diagnostic Markers NCT03228095	University of Latvia	—
Terminated	Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients NCT04140591	Taipei Veterans General Hospital, Taiwan	Phase 2 / Phase 3
Unknown	Helicobacter Pylori Antibiotic Susceptibility Testing of Korea NCT02961296	Asan Medical Center	—
Unknown	Efficacy of Low Dose Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding NCT03814421	Samsung Changwon Hospital	N/A
Completed	The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients NCT02648659	Kyungpook National University Hospital	Phase 4
Completed	Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy NCT02633930	Xijing Hospital of Digestive Diseases	Phase 4
Completed	The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers NCT02581696	Boryung Pharmaceutical Co., Ltd	Phase 1
Unknown	WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal Endoscopy NCT02436018	RenJi Hospital	N/A
Completed	Bleeding Ulcer and Erosions Study "BLUE Study" NCT03367897	Ostfold Hospital Trust	—
Completed	Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users NCT02342470	PharmaKing	Phase 2
Completed	Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy NCT02296021	Xijing Hospital of Digestive Diseases	Phase 4
Completed	Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication NCT02175901	Shanghai Jiao Tong University School of Medicine	Phase 4
Unknown	Adverse Events During Upper Gastrointestinal Endoscopy NCT01979549	RenJi Hospital	—
Completed	Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery NCT01838109	Seoul National University Hospital	N/A
Completed	Residual Gastric Volume After the Ingestion of a Beverage Containing Carbohydrates Plus Whey Protein NCT01828645	Federal University of Mato Grosso	Phase 2 / Phase 3
Completed	Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment NCT02084420	Il-Yang Pharm. Co., Ltd.	Phase 3
Completed	Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori NCT01667575	Shanghai Jiao Tong University School of Medicine	Phase 4
Completed	Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers NCT02551744	Kaohsiung Veterans General Hospital.	N/A
Completed	Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment NCT01667718	Shanghai Jiao Tong University School of Medicine	Phase 4
Unknown	HEP-FYN 12-Years Follow-up NCT02001727	Odense University Hospital	N/A
Completed	Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer NCT02418312	Kaohsiung Veterans General Hospital.	N/A
Completed	Clarithromycin Resistant Tailored Therapy NCT01453036	Jin Il Kim	Phase 4
Completed	H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department NCT01376414	George Washington University	—
Completed	Aizthromycin or Clarithromycin in H-pylori Eradication Regimen NCT01667692	Shahid Sadoughi University of Medical Sciences and Health Services	Phase 4
Completed	Rapid Urease Test for Diagnosis of H. Pylori Infection in Patients With Peptic Ulcer Bleeding NCT01282853	Far Eastern Memorial Hospital	N/A
Completed	PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers NCT01180179	Chinese University of Hong Kong	Phase 4
Completed	Feasibility of Translumenal Endoscopic Omental Patch Closure of Perforated Viscus NCT01080326	Mayo Clinic	N/A
Completed	Early Selective TAE to Severely Bleeding Peptic Ulcers After Their Initial Endoscopic Hemostasis NCT01142180	Chinese University of Hong Kong	N/A
Completed	Drop in Gastroscopy - Experience After 9 Months NCT00977678	Norwegian Department of Health and Social Affairs	—
Completed	Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent Clot NCT02536989	Far Eastern Memorial Hospital	Phase 4
Unknown	Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inh NCT00854776	Taipei Veterans General Hospital, Taiwan	N/A
Completed	Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer NCT01138969	Kaohsiung Veterans General Hospital.	Phase 2
Completed	Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal Tract NCT00920400	University Hospital, Basel, Switzerland	—
Unknown	High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined NCT00709046	National Taiwan University Hospital	N/A
Completed	Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic The NCT01142245	Chinese University of Hong Kong	Phase 3
Completed	A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers NCT01353144	Kaohsiung Veterans General Hospital.	Phase 4
Terminated	TAE and Surgery in Patients With Peptic Ulcer Bleeding Uncontrolled by Endoscopic Therapy NCT00766961	Chinese University of Hong Kong	N/A
Completed	Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers NCT00450658	Amgen	Phase 3
Unknown	The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After Antrectom NCT00441831	Mackay Memorial Hospital	—
Completed	Importance of Cytokines in Peptic Ulcer Disease: Implications for Treatment NCT00534443	University of Athens	Phase 4
Completed	AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Heal NCT00325715	Allergan	Phase 1
Unknown	Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patient NCT00471029	Pamela Youde Nethersole Eastern Hospital	Phase 4
Unknown	On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication NCT00161096	UMC Utrecht	Phase 3
Completed	Administration of High-Dose Intravenous Proton Pump Inhibitor for Upper Gastrointestinal Bleeding Prior to End NCT00164866	Chinese University of Hong Kong	Phase 4
Completed	A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin NCT00175032	Takeda	Phase 3
Completed	Natural History of Non-steroidal Anti-inflammatory Drug and Non-Helicobacter Pylori in Bleeding Peptic Ulcers NCT00153712	Chinese University of Hong Kong	—
Completed	Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestina NCT00152399	UCB Pharma	Phase 2
Completed	Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori) NCT00212225	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	—
Withdrawn	Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding NCT00881413	Lotung Poh-Ai Hospital	Phase 4